134 related articles for article (PubMed ID: 9883003)
1. Fever as presenting symptom of multiple myeloma.
Pitz CC; Lokhorst HM; Hoekstra JB
Neth J Med; 1998 Dec; 53(6):256-9. PubMed ID: 9883003
[TBL] [Abstract][Full Text] [Related]
2. High dose dexamethasone as first line therapy of multiple myeloma? A case report.
Meregalli M; Bertola G; Grando D
Recenti Prog Med; 1998 Jan; 89(1):18-20. PubMed ID: 9549388
[TBL] [Abstract][Full Text] [Related]
3. Gastric invasion of multiple myeloma presenting as gastrointestinal bleeding.
Nakajima K; Sueki Y; Koshiishi M; Kawashima I; Nozaki Y; Mitsumori T; Kirito K
Int J Hematol; 2015 Jun; 101(6):525-6. PubMed ID: 25916464
[No Abstract] [Full Text] [Related]
4. [Improved prognosis of generalized AL-amyloidosis in a patient with multiple myeloma treated according to the VAD protocol].
Sarkisova IA; Rameev VV; Kozlovskaia LV; Andreeva NE
Ter Arkh; 2003; 75(8):81-2. PubMed ID: 14520860
[No Abstract] [Full Text] [Related]
5. Amyloid deposition of systemic myeloma-associated amyloidosis excludes actinic elastotic material.
Wada N; Fujimoto N; Komatsu T; Tajima S; Ishibashi A
Eur J Dermatol; 2002; 12(6):607-8. PubMed ID: 12459542
[TBL] [Abstract][Full Text] [Related]
6. An unusual case of pulmonary hypertension in a young male.
Rostagno C; Ciolli S; Prisco D
Intern Emerg Med; 2006; 1(2):127-32. PubMed ID: 17111785
[No Abstract] [Full Text] [Related]
7. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
[TBL] [Abstract][Full Text] [Related]
8. Treatment of multiple myeloma: 2009 update.
Prescrire Int; 2009 Dec; 18(104):263-6. PubMed ID: 20025098
[TBL] [Abstract][Full Text] [Related]
9. VBAMDex chemotherapy in advanced multiple myeloma.
Peest D; Schmoll HJ; Schedel I; Glück S; Schumacher K; Deicher H
Eur J Haematol; 1988 Mar; 40(3):245-9. PubMed ID: 3356240
[TBL] [Abstract][Full Text] [Related]
10. VAD followed by VMCP: an alternative regimen for multiple myeloma.
Wadhwa J; Kumar L; Kochupillai V
Med Oncol; 2002; 19(2):105-8. PubMed ID: 12180477
[TBL] [Abstract][Full Text] [Related]
11. The treatment of multiple myeloma.
Alexanian R; Dimopoulos M
N Engl J Med; 1994 Feb; 330(7):484-9. PubMed ID: 8289856
[No Abstract] [Full Text] [Related]
12. Modifications to therapy for multiple myeloma: pegylated liposomal Doxorubicin in combination with vincristine, reduced-dose dexamethasone, and thalidomide.
Hussein MA
Oncologist; 2003; 8 Suppl 3():39-45. PubMed ID: 14671227
[TBL] [Abstract][Full Text] [Related]
13. Assessment of early paraprotein response to vincristine-doxorubicin-dexamethasone chemotherapy may help guide therapy in multiple myeloma.
Ross DM; To LB; Horvath N
Intern Med J; 2004; 34(9-10):576-8. PubMed ID: 15482273
[TBL] [Abstract][Full Text] [Related]
14. Multiple myeloma with paraneoplastic leucocytoclastic vasculitis.
Jain P; Kumar P; Parikh PM
Indian J Cancer; 2009; 46(2):173-4. PubMed ID: 19346655
[No Abstract] [Full Text] [Related]
15. [IgD myeloma manifesting as acute renal insufficiency].
Duvic C; Sarret D; De Revel T; Hérody M; Didelot F; Labaye J; Nédélec G
Rev Med Interne; 2000 Sep; 21(9):799-803. PubMed ID: 11039177
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of rhIL-6 (interleukin-6) prior to and concurrently with VAD (vincristine, doxorubicin and dexamethasone) chemotherapy for patients with multiple myeloma.
Young RI; Ranson M; Chang J; Lord B; Testa N; Scarffe JH
Eur J Cancer; 1997 Feb; 33(2):307-11. PubMed ID: 9135507
[TBL] [Abstract][Full Text] [Related]
17. Remission of collapsing focal segmental glomerulosclerosis following chemotherapy for myeloma.
Shah S; Cavenagh J; Sheaf M; Thuraisingham RC
Am J Kidney Dis; 2004 Feb; 43(2):e10-2. PubMed ID: 14750118
[TBL] [Abstract][Full Text] [Related]
18. Multiple myeloma: biology and therapy.
Barlogie B; Epstein J
J Cancer Res Clin Oncol; 1990; 116(1):109-11. PubMed ID: 2312600
[No Abstract] [Full Text] [Related]
19. Is there still place for VAD as primary treatment for patients with multiple myeloma who are candidates for high-dose therapy?
Dimopoulos MA; Kastritis E
Leuk Lymphoma; 2006 Nov; 47(11):2271-2. PubMed ID: 17107895
[No Abstract] [Full Text] [Related]
20. Bilateral transient hearing loss associated with vincristine therapy: case report.
Aydogdu I; Ozturan O; Kuku I; Kaya E; Sevinc A; Yildiz R
J Chemother; 2000 Dec; 12(6):530-2. PubMed ID: 11154039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
